34 completed, 16 active not recruiting, 13 terminated, 11 recruiting. 30 Not applicable, 20 Phase 2, 19 Phase 1, 4 Early Phase 1, 4 Phase 3.
Follow this condition Literature Review of Anatomic Stage IIIA Breast Cancer AJCC v8 trials Research Report on Anatomic Stage IIIA Breast Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Physical Activity Program Compared to Health Education for Improving Memory and Attention in Hispanic Women With Newly-Diagnosed Stage I-IIIa Breast Cancer, MAMA Trial Accelerometry, Aerobic Exercise, Electronic Health Record Review - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Not yet recruiting | Mayo Clinic | 10 | 2026-10-01 | 2026-06-16 |
| Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial Anastrozole, Biospecimen Collection, Bone Scan - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 3 | Recruiting | National Cancer Institute (NCI) | 1978 | 2026-08-10 | 2026-10-20 |
| Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer Ipilimumab, Pembrolizumab, Vaccine Therapy - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1 | Recruiting | Emory University | 18 | 2025-12-02 | 2026-01-26 |
| Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC Biospecimen Collection, Breast Biopsy Procedure, Carboplatin - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 2 | Recruiting | Vandana Abramson | 51 | 2025-09-09 | 2025-10-30 |
| High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer Biospecimen Collection, BRC-001, Placebo Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Suspended | City of Hope Medical Center | 36 | 2024-08-26 | 2026-07-14 |
| Breast Cancer, Reasoning, and Activity Intervention Aerobic Exercise Training, Health Education (Active comparator) - Breast Cancer, Breast Neoplasms | Not applicable | Recruiting | Mayo Clinic | 160 | 2024-02-22 | 2026-09-08 |
| Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer Biospecimen Collection, Carboplatin, Cyclophosphamide - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 3 | Recruiting | SWOG Cancer Research Network | 2400 | 2023-09-15 | 2025-11-05 |
| Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab Pembrolizumab, Patient Observation, Biopsy - Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma | Phase 3 | Recruiting | Alliance for Clinical Trials in Oncology | 1295 | 2023-06-14 | 2026-08-05 |
| Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer Minoxidil, Quality-of-Life Assessment, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Early Phase 1 | Recruiting | Ohio State University Comprehensive Cancer Center | 50 | 2023-03-01 | 2026-03-10 |
| STEMVAC in Patients With Early Stage Triple Negative Breast Cancer CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine, Sargramostim - Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Active not recruiting | University of Washington | 33 | 2022-11-17 | 2026-07-23 |
| Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors Patient Navigation, Quality-of-Life Assessment, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 21 | 2022-11-14 | 2025-03-25 |
| Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer Transcutaneous Electrical Nerve Stimulation - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Terminated | Emory University | 17 | 2022-10-19 | 2026-05-18 |
| Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Behavioral Assessment, Electronic Health Record Review - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Terminated | M.D. Anderson Cancer Center | 27 | 2022-08-15 | 2024-08-26 | |
| Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer Best Practice, Biopsy, Biospecimen Collection - Advanced Breast Adenocarcinoma, Advanced HER2-Negative Breast Carcinoma | Not applicable | Withdrawn | City of Hope Medical Center | 2022-07-03 | 2022-06-09 | |
| Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors Dietary Intervention - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Withdrawn | City of Hope Medical Center | 2022-06-15 | 2022-06-09 | |
| Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors Educational Intervention, Quality-of-Life Assessment, Questionnaire Administration - Breast Cancer, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Terminated | University of Alabama at Birmingham | 27 | 2022-06-01 | 2026-05-07 |
| A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment Best Practice, Educational Intervention, Quality-of-Life Assessment - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Terminated | University of Alabama at Birmingham | 37 | 2022-06-01 | 2026-05-06 |
| Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel - Advanced Breast Carcinoma, Advanced Endometrial Carcinoma | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 43 | 2022-04-29 | 2026-07-16 |
| Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer Carboplatin, Docetaxel, Fulvestrant - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 | Phase 1 / Phase 2 | Active not recruiting | Jonsson Comprehensive Cancer Center | 18 | 2022-04-07 | 2026-05-11 |
| Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 138 | 2022-03-31 | 2026-08-20 |
Showing 20 of 84. Sign in to see all of them.
Breast Neoplasms (19) · Triple Negative Breast Neoplasms (18) · Breast Carcinoma In Situ (13) · Ovarian Neoplasms (7) · Carcinoma, Intraductal, Noninfiltrating (5) · Neoplasm Metastasis (5) · Lung Neoplasms (4) · Prostatic Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (3) · Colorectal Neoplasms (3) · Endometrial Neoplasms (3) · Overweight (3) · Uterine Cervical Neoplasms (3) · Brain Neoplasms (2) · Carcinoma, Hepatocellular (2)
Neoplasms (51) · Neoplasms by Site (48) · Breast Diseases (41) · Skin Diseases (41) · Skin and Connective Tissue Diseases (41) · Breast Neoplasms (22) · Neoplasms by Histologic Type (21) · Carcinoma (20) · Neoplasms, Glandular and Epithelial (20) · Carcinoma in Situ (16) · Genital Diseases (11) · Urogenital Diseases (11) · Pathological Conditions, Signs and Symptoms (10) · Adenocarcinoma (9) · Female Urogenital Diseases (9)
Taxes (12) · Practice Guidelines as Topic (10) · Paclitaxel (9) · Standard of Care (9) · Specimen Handling (7) · pembrolizumab (6) · Albumin-Bound Paclitaxel (5) · Carboplatin (5) · Cyclophosphamide (5) · Docetaxel (5) · Interviews as Topic (5) · Magnetic Resonance Spectroscopy (5) · 130-nm albumin-bound paclitaxel (4) · Biopsy (4) · Early Intervention, Educational (4)
M.D. Anderson Cancer Center (21) · Mayo Clinic (11) · Ohio State University Comprehensive Cancer Center (11) · Jonsson Comprehensive Cancer Center (5) · City of Hope Medical Center (3) · Emory University (3) · Fred Hutchinson Cancer Center (3) · National Cancer Institute (NCI) (3) · Alliance for Clinical Trials in Oncology (2) · ECOG-ACRIN Cancer Research Group (2) · OHSU Knight Cancer Institute (2) · SWOG Cancer Research Network (2) · Thomas Jefferson University (2) · University of Alabama at Birmingham (2) · University of California, San Francisco (2)
United States (77) · Puerto Rico (5) · Mexico (2) · Canada (1) · Chile (1) · Colombia (1) · Uganda (1)
Meghan Karuturi (3) · Patricia A Ganz (2) · Senthilkumar Damodaran (2) · Timiya Nolan, PhD (2) · William Carson, MD (2) · Abenaa M Brewster (1) · Alexandra Zimmer, M.D. (1) · Alison M Schram (1) · Amy J Chien, MD (1) · Anita H. Chen, M.D. (1) · Apostolia M Tsimberidou (1) · Azadeh Nasrazad, MD,PHD (1) · Banu Arun (1) · Brent A. Bauer, M.D. (1) · Brian C Focht, PhD (1)
PMID 33142018, PMID 34782341, PMID 35727609, PMID 35788100, PMID 36336249, PMID 36351402, PMID 36609349, PMID 36658425, PMID 37621406, PMID 37823909, PMID 38828938, PMID 39325778, PMID 39865083, PMID 40939237, PMID 40966714, PMID 41213254, PMID 41271741, PMID 42623567, PMID 42804742
P30CA033572 (3), P30CA138292 (3), P30CA012197 (2), P30CA014089 (2), U10CA180820 (2), K08CA245208 (1), P30CA015083 (1), P30CA015704 (1), P30CA016058 (1), P30CA016672 (1), P30CA023074 (1), P30CA068485 (1), P50CA116201 (1), R01CA105023 (1), R01CA222246 (1)